Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, NZS Capital - Growth. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD+24.76%
YTD+13.63%
Annualized+16.68%
Positioning StanceNEUTRAL
GeographyGlobal
Digest Analysis
Quick Take
"The manager re-entered NVIDIA at attractive valuations while trimming momentum winners back to optionality. Healthcare presents compelling opportunities with improving fundamentals and multiple compression creating entry points."
Executive Summary
NZS Capital's Growth Equity strategy returned 24.76% net in Q2 2026, outperforming the index by 9.96% as seemingly insatiable AI infrastructure demand drove strength in semiconductors. All five top contributors came from the semiconductor industry and AI ecosystem, including ARM Holdings, Lam Research, ASML, Taiwan Semiconductor, and Marvell. The manager added NVIDIA back to the portfolio as a resilient position after exiting in Q3 2025, believing lowered valuations compensate for GPU market share risks. The team actively trimmed positions that outperformed into the middle of the portfolio back to optionality, maintaining strict discipline on risk management. Quanta Services was promoted to resilient given narrowing outcomes for grid infrastructure. The manager finds Healthcare increasingly attractive following post-pandemic recovery, with fundamentals returning to growth and the sector offering portfolio construction benefits by being untethered to AI capex. Despite steep derating in quality growth stocks outside AI, the team added materially to Intuitive Surgical, Axogen, and other healthcare names. The portfolio remains overweight Information Technology, Industrials, and Healthcare with 50-65 concentrated positions.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
Market Conviction
68%
CautiousHigh
Moderate (68%)
The portfolio holds 50-65 concentrated positions with clear thesis articulation for major holdings. The manager names specific positions, discusses sizing decisions explicitly (promoting Quanta to resilient, trimming four names back to optionality, adding materially to four names), and provides falsifiable reasoning for each decision. NVIDIA was added back with specific rationale about valuation compensating for market share risks. The Healthcare thesis is detailed with multiple supporting arguments. However, the portfolio is not extremely concentrated (50-65 names is moderate), and the manager maintains optionality positions alongside resilient positions, indicating a tiered conviction approach rather than all-in concentration. The strict discipline around trimming outperformers back to optionality demonstrates conviction in the process but also acknowledgment of uncertainty in individual position outcomes.
Growth Outlook
63%
BearishBullish
Neutral (63%)
The manager describes equity markets as strong in Q2 2026 and notes that Q1 weakness provided some of the most attractive valuations in growth equities seen in some time. The letter references seemingly insatiable demand for AI infrastructure, progress towards geopolitical stabilization, and generally positive earnings reports. The manager identifies specific attractive opportunities in Healthcare and views improving fundamentals across multiple sectors. However, the manager also acknowledges significant multiple compression in quality growth stocks and higher interest rate expectations weighing on valuations, preventing a more bullish score.
Risk Appetite
55%
DefensiveAggressive
Balanced (55%)
The portfolio is actively deployed with overweight positions in Information Technology, Industrials, and Healthcare. The manager added NVIDIA back as a resilient position and materially increased positions in ASML, Amphenol, Intuitive Surgical, and Axon. New optionality positions were opened in seven companies. However, the manager also trimmed four positions back to optionality after they outperformed, demonstrating disciplined risk management. The active net additions to IT, Healthcare, and Communication Services alongside material position increases indicate a moderately risk-on posture, though the trimming activity and strict position sizing discipline prevent a higher score.
Capital Deployment
35%
De-riskingDeploying
Net Neutral (35%)
The manager actively added net basis points to Information Technology, Healthcare, and Communication Services while reducing exposure to Consumer Discretionary, Real Estate, and Financials. Seven new optionality positions were opened and material capital was added to four existing positions (ASML, Amphenol, Intuitive Surgical, Axon). However, this deployment was offset by trimming four positions back to optionality after they outperformed. No cash level data is provided, but the pattern of activity suggests selective rotation and modest net deployment rather than aggressive capital deployment. The manager describes adding incrementally to Healthcare and selectively to other areas, indicating measured rather than aggressive deployment.
Forward Guidance
45%
CautiousExpansionary
Neutral (45%)
The manager expresses intent to continue benefiting from AI infrastructure demand and states that a modestly higher dose of Healthcare is good for portfolio health, indicating selective deployment bias. However, the forward guidance is measured rather than aggressive. The manager emphasizes maintaining strict discipline on position sizing and trimming positions that outperform into the middle back to optionality. The language suggests selective adding in specific areas rather than broad-based deployment, with emphasis on watching for the right entry points and maintaining risk discipline.
Language Signal
40%
BearishBullish
Balanced (40%)
The letter contains meaningful bullish language around AI infrastructure demand being seemingly insatiable, attractive valuations in growth equities, improving fundamentals in Healthcare, and strengthening tailwinds for semiconductor equipment. However, this is balanced by significant discussion of risks including steep derating in quality growth stocks, multiple compression, higher interest rate expectations weighing on valuations, and widening range of outcomes for many sectors due to AI disruption. The manager uses cautious language around capital being reallocated away from quality growth and expresses surprise at the extent of multiple compression in Healthcare. The net balance leans mildly positive but is substantially hedged.
Perceived Risk
52%
Low RiskElevated
Moderate Risk (52%)
The manager identifies several specific risks with meaningful discussion: steep derating in quality growth stocks with valuations cut significantly, capital reallocation from quality growth to AI creating market distortions, higher interest rate expectations weighing on valuations, widening range of outcomes for multiple sectors due to AI disruption, and GPU market share risks for NVIDIA. The letter devotes substantial space to discussing the quality growth derating phenomenon and its implications. However, the manager does not express alarm or systemic concern, instead framing most risks as understandable market dynamics or manageable through positioning. The risks are acknowledged and incorporated into decision-making rather than treated as existential threats.
Opportunity Density
62%
ScarceAbundant
Selective (62%)
The manager identifies attractive opportunities across multiple areas: AI infrastructure and semiconductors showing strong momentum, Healthcare presenting compelling entry points after multiple compression despite improving fundamentals, and grid infrastructure with narrowing range of outcomes. Seven new optionality positions were opened during the quarter. The manager describes Q1 weakness as providing some of the most attractive valuations in growth equities seen in some time. However, the opportunity set is characterized as selective rather than broad-based, with emphasis on specific sectors and themes rather than opportunities across the entire market. The steep derating in quality growth stocks outside AI suggests a bifurcated market with opportunities concentrated in specific areas.
Time Horizon
68%
Short-TermLong-Term
Multi-Year (68%)
The manager operates with a multi-year framework, discussing fundamental range of outcomes narrowing over time for positions like Quanta Services and evaluating whether stocks should be promoted to resilient or remain optional based on long-term outcome ranges. The Healthcare thesis incorporates longer-term structural trends like GLP-1 adoption impacts, AI in drug discovery, and BIOSECURE Act effects that will play out over years. The decision to re-enter NVIDIA is based on valuation compensating for risks over time rather than near-term catalysts. However, the manager also discusses quarterly earnings, near-term guidance disappointments (Nintendo), and specific events like Jensen Huang's comments at Computex, indicating attention to medium-term catalysts alongside the longer-term framework. The portfolio structure with 50-65 names and quarterly rebalancing suggests a 2-4 year typical holding period rather than permanent capital.